Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial.

Saved in:
Bibliographic Details
Title: Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial.
Authors: Han WM; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand.; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia., Solomon SS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Smeaton L; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Avihingsanon A; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand., Wagner Cardoso S; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil., Li J; Gilead Sciences, Inc., Foster City, California, USA., Parvangada A; Gilead Sciences, Inc., Foster City, California, USA., Sulkowski M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Naggie S; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA., Martin R; Gilead Sciences, Inc., Foster City, California, USA., Mo H; Gilead Sciences, Inc., Foster City, California, USA., Maiorova E; Gilead Sciences, Inc., Foster City, California, USA., Wyles D; Department of Medicine, Denver Health Medical Center, Denver, Colorado, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Jul 18; Vol. 80 (6), pp. 1293-1301.
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39702964
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Han+WM%22">Han WM</searchLink>; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand.; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Solomon+SS%22">Solomon SS</searchLink>; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Smeaton+L%22">Smeaton L</searchLink>; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Avihingsanon+A%22">Avihingsanon A</searchLink>; The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Wagner+Cardoso+S%22">Wagner Cardoso S</searchLink>; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Parvangada+A%22">Parvangada A</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Sulkowski+M%22">Sulkowski M</searchLink>; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Naggie+S%22">Naggie S</searchLink>; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Martin+R%22">Martin R</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Mo+H%22">Mo H</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Maiorova+E%22">Maiorova E</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Wyles+D%22">Wyles D</searchLink>; Department of Medicine, Denver Health Medical Center, Denver, Colorado, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2025 Jul 18; Vol. 80 (6), pp. 1293-1301.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39702964
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciae627
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1293
    Titles:
      – TitleFull: Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Han WM
      – PersonEntity:
          Name:
            NameFull: Solomon SS
      – PersonEntity:
          Name:
            NameFull: Smeaton L
      – PersonEntity:
          Name:
            NameFull: Avihingsanon A
      – PersonEntity:
          Name:
            NameFull: Wagner Cardoso S
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Parvangada A
      – PersonEntity:
          Name:
            NameFull: Sulkowski M
      – PersonEntity:
          Name:
            NameFull: Naggie S
      – PersonEntity:
          Name:
            NameFull: Martin R
      – PersonEntity:
          Name:
            NameFull: Mo H
      – PersonEntity:
          Name:
            NameFull: Maiorova E
      – PersonEntity:
          Name:
            NameFull: Wyles D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 07
              Text: 2025 Jul 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1